Abdul Mannan on Finding the Right Balance – The Blood Thinner Dilemma
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, posted on LinkedIn:
”Stopping blood thinners after a clot is tricky. You might stop too soon and get another clot. Or you might stay on them too long and bleed.
We used to rely on fancy scores and tests. Now guidelines say don’t bother with most of them. Just talk to your patient.
If the clot had no clear cause, you probably need longer treatment. If it happened after surgery, you can stop sooner.
Cancer patients stay on treatment whilst the cancer is active. Simple as that.
Three months treats the clot. After that, you’re preventing the next one. That’s when the hard choices start.
Some tools help predict risk. But ASH says use them only if they’ll actually change your plan. Otherwise, skip them.
Lower doses work for prevention after the first months. Balance is everything.”
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 07:22Poppy Clarke: Turning Steps Into Support for Thrombosis Awareness
-
Oct 10, 2026, 07:12Hamzah Khan: The Role of Genuine Curiosity in Driving High-Impact Academic Research
-
Oct 10, 2026, 06:58Nita Radhakrishnan: Turning Evidence Into Action for Hemophilia Care in India
-
Oct 10, 2026, 06:48Nutan Kaushik: HemeNext 2.0 Brings Global Perspectives to Hematology
-
Oct 10, 2026, 06:43Suthesh Sivapalaratnam: Advancing Bleeding Disorder Care at EHC 2026
-
Oct 10, 2026, 02:38Brianne D.: Sex Differences in RIPK1 Signaling Following Intracerebral Hemorrhage
-
Oct 10, 2026, 02:17Dino Mehic: Managing Heavy Menstrual Bleeding in Patients with BDUC
-
Oct 10, 2026, 00:34Raphaëlle Dodart: Discussing the Mechanisms of Menstrual Hemostasis
-
Oct 10, 2026, 00:26Barbara Adams Krolak: Discussing the Growing Need for Blood Clot Prevention in Asia